Yu-Kai Su

Papers

Total Citations

H-Index

About

Yu-Kai Su is a clinical researcher whose work bridges endocrinology and oncology, with a particular focus on the role of sex hormones in prostate cancer pathogenesis. His most-cited study, "Low levels of serum testosterone in middle-aged men impact pathological features of prostate cancer" (2017, 13 citations), investigates the relationship between age-related testosterone decline and tumor characteristics. This work challenges conventional assumptions by demonstrating that low preoperative serum testosterone in middle-aged men is associated with more aggressive pathological features of prostate cancer, offering critical insights into how hormonal changes with aging may influence disease progression. Su’s research highlights the importance of considering endocrine status in risk stratification and treatment planning for prostate cancer patients. His findings contribute to a growing body of evidence that serum testosterone levels could serve as a biomarker for tumor biology, potentially guiding more personalized therapeutic approaches. By connecting age-related hormonal shifts to cancer pathology, Su provides a nuanced perspective that is valuable for both clinicians and researchers studying the intersection of aging, hormones, and malignancy.